(13-329) Euglycemic Diabetic Ketoacidosis: Institutional Review and Protocol Development

Wednesday, December 10, 2025

3:15 PM - 4:15 PM

Location: Bayside A, Level 1

Residency Program: Swedish Medical Center - Seattle
Residency Program Type: PGY2 (Critical Care Pharmacy)
Residency Program Location: Washington

Co-Author(s): Jordan Amaro, Brittanii Prahl, Jack Huber

Primary Author(s)

Lim Kang, PharmD

PGY-2 Critical Care Pharmacy Resident/Pharmacist
Swedish Medical Center